Patent US3869444A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3869444A Expired / Lapsed US ⏱️ 0.0 years remaining

Esters of erythromycin oxime

Assignee: Abbott Laboratories
•
Filing: 1972-10-10
•
Granted: 1975-03-04
•
Expires: 1992-10-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Covers stable oxime esters of erythromycin oximes, which are active antibiotic agents.

Inventors

  • 👤 Leslie Alan Freiberg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 01:50
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/16; C07D295/18; C07D295/182; C07D295/192; C07C; C07C63/00; C07C63/68; C07C63/70; C07H; C07H17/00; C07H17/04; C07H17/08

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 11 words
THE COMPOUND 9-(10)-(2,6-DIMETHYL-4CARBOMETHOXY)BENZOYLERYTHROMYCIN A OXIME HAVING THE FOLLOWERING GENERAL STRUCTURAL FORMULA
Claim 2
Dependent Claim 11 words
THE COMPOUND 9-(10)-(2,6-DIMETHYL-4CARBOMETHOXY)BENZOYLERYTHROMYCIN A OXIME HAVING THE FOLLOWERING GENERAL STRUCTURAL FORMULA
Claim 3
Dependent Claim 10 words
The compound of claim 1 which is 9-(0)-(2,6-dimethyl-4-carbomethoxy)benzoylerythromycin B oxime.
Claim 4
Dependent Claim 10 words
The compound of claim 1 which is 9-(0)-(2,6-dimethyl-4-benzyloxYcarbonyl)benzoylerythromycin B oxime.
Claim 5
Dependent Claim 10 words
The compound of claim 1 which is 9-(0)-(2,6-dimethyl-4-(N-n-butylcarbomyl))benzoylerythromycin B oxime.
Claim 6
Dependent Claim 10 words
The compound of claim 1 which is 9-(0)-(2,6-dimethyl-4-(N-morpholinylcarbonyl))benzoylerythromycin B oxime.
Claim 7
Dependent Claim 10 words
The compound of claim 1 which is 9-(0)-(2,6-dimethyl-4-(N-methylpiperazinylcarbonyl)benzoylerythromycin B oxime.
Claim 8
Dependent Claim 11 words
The compound of claim 1 which is 9-(0)-(2,6-dimethyl-4-(N-(2-hydroxypropyl)-N-piperazinyl carbonyl))benzoylerythromycin B oxime.
Claim 9
Dependent Claim 10 words
The compound of claim 1 which is 9-(0)-(2,6-dimethyl-4-(4-methyl-1-pentyloxycarbonyl))benzoylerythromycin B oxime.
Claim 10
Dependent Claim 12 words
The compound of claim 1 which is 9-(0)-(2,6-dimethyl-4-(3-(N, N-dimethylamino)propyloxy carbonyl))benzoylerythromycin B oxime.
Claim 11
Dependent Claim 10 words
The compound of claim 1 which is 9-(0)-(2,6-dimethyl-4-(N-(4-methyl-1-pentyl)carbamyl))benzoylerythromycin B oxime.
Claim 12
Dependent Claim 11 words
The compound of claim 1 which is 9-(0)-(2,6-dimethyl-4-(3-(N,N-dimethylamino)propyl carbamyl))benzoylerythromycin B oxime.
Claim 13
Dependent Claim 10 words
The compound of claim 1 which is 9-(0)-(2,6-dimethyl-4-carboxy)benzoylerythromycin B oxime.
Claim 14
Dependent Claim 10 words
The compound of claim 1 which is 9-(0)-(2,6-dimethyl-4-(N,N-dimethylaminomethyl))benzoylerythromycin B oxime.
Claim 15
Dependent Claim 10 words
The compound of claim 1 which is 9-(0)-(2,6-dimethyl-4-(n-butyloxycarbonyl))benzoylerythromycin B oxime.

References Cited (Backward Citations)

US3574185A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-03-03 1978-09-02 1979-03-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-03-03 1982-09-02 1983-03-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-03-03 1986-09-02 1987-03-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag